medigraphic.com

2006, Number S2

<< Back Next >>

Arch Cardiol Mex 2006; 76 (S2)

Cardiovascular risk stratification

Martínez RJ

Language: Spanish
References: 25
Page: 176-181
PDF size: 95.38 Kb.


ABSTRACT

In often cited statistic cardiovascular disease is the number 1 cause of death in the worldwide and lot only in the developed world. This represents an aggressive identification and management of risk factors. With the many advances in our understanding and practices of risk factor management we hope to change this tendency predicted to be in 2020 the same. Now we know that exists major factor risk and others who predispose. The presence of major risk factors was associated with development of cardiovascular disease. The process of risk factor management is a multidisciplinary one, directly involving both the patient his doctor as well as many others, including nurses, other healthcare and family. The goal is preventing future cardiac events.


REFERENCES

  1. LIBBY P: The forgotten Majority. J Am Cardiol 2005; 46: 1225-8.

  2. GREENLAND P: Mayor risk factor as antecedents of factor of nonfatal coronary heart disease events. JAMA 2003; 290: 891-7.

  3. RIDKER PM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363-9.

  4. RIDKER PM: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 2003; 107: 391-7.

  5. NATHAM DM: Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med 2003; 348: 2294-03.

  6. WILSON PW, D’ AGOSTINO RB, LEVY D, BELANGER AM, SILBERHATZ H, KANNEL WB: Prediction of coronary heart disease using factor categories. Circulation 1998; 97: 1837-47.

  7. SCOTT M, GRUNDY, PASTERNAK R, GREENLAND P, SMITH S, FUSTER V: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. J Am Coll Cardiol 1999; 34: 1348-59.

  8. KRIEGER DR, LANDSBERG L: Mechanisms in obesity-related hypertension: role of insulin and catecholamines. Am J Hypertens 1988; 1: 84-90.

  9. NHLBI Obesity Education Initiative Expert Panel. Clinical Guidelines on Identification. Evaluation, and treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda, Md: National Institutes of Health, National Heart, Lung, and Blood Institute: 1998.

  10. DENKE MA, SEMPOS CT, GRUNDY SM: Excess body weight: an underrecognized contributor to high blood cholesterol levels in white American men. Arch Intern Med 1993; 153: 1093-03.

  11. TCHERNOF A, LAMARCHE B, PRUD’HOMME D, ET AL: The dense LDL phenotype : association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 1996; 19: 629-37.

  12. ABATE N, GARG A, PESHOCK RM, STRAY-GUNDERSEN J, GRUNDY SM: Relationship of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995; 96; 88-98.

  13. GILTAY EJ, ELBERS JM, GOOREN LJ, EMEIS JJ, KOOISTRA T, ASSCHEMAN H, STEHOUWER CD: Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration. Arterioscler Thromb Vasc Biol 1998; 18: 1716-22.

  14. FLETCHER GF, BALADY G, BLAIR SN, ET AL : Statment on exercise : benefits and recommendations for physical activity programs for all Americans : a statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation 1996; 94: 857-62.

  15. FLETCHER GF: How to implement physical activity in primary and secondary prevention: a statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association. Circulation 1997; 96: 355-7.

  16. MYERS RH, KIELY DK, CUPPLES LA, KANNEL WB: Parenteral history is an independent risk factor for coronary artery disease: The Framingham Study. Am Heart J 1990; 120: 963-9.

  17. KING KB, Psychologic and social aspects of cardiovascular disease. Ann Behav Med 1997; 19: 264-70.

  18. GOLF DC, NICHAMAN MZ, CHAN W, RAMSEY DJ, LABARTHE C: Greater incidence of hospitalized myocardial infarction among Mexican Americans than non-Hispanic whites and men: the Corpus Christi Heart Project, 1988-1992. Circulation 1997; 95: 1433-40.

  19. ASSMAN G, SCHULTE H, FUNKE H, VON ECKARDSTEIN A: The emergence of triglycerides as a significant independent risk factor in coronary artery disease. Eur Heart J 1998; 19 Suppl M: M8-14.

  20. PERSEGHIN G, PRICE TB, PETERSEN KF, ET AL: Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med 1996; 335: 1357-62.

  21. MAYER EL, JACOBSEN DW, ROBINSON K: Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996; 27: 517-27.

  22. EDA S. KAUFMANN J, ROOS W, POHL S: Development of a new microparticle-enhaced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range. J Clin Lab Anal 1998; 12: 137-44.

  23. WILSON PW: 34th Bethesda Conference: Taskforce 4, how to we select patients for atherosclerosis imaging? J Am Coll Cardiol 2003; 41: 1898-906.

  24. TZOU W, DOUGLAS P, SATHANUR R, BOND M, ET AL: Increased subclinical atherosclerosis in young adults with metabolic syndrome. J Am Coll Cardiol 2005; 46: 457-63.

  25. RAFF G, GALLAGHER M, O’NEILL W, GOLDSTEIN J: Diagnostic accuracy of noninvasive coronary angiography using 64-slice spiral computed tomography. J Am Coll Cardiol 2005; 46: 552-7.




2020     |     www.medigraphic.com